A new study from a pharmacy benefit manager is casting doubt on the benefits of GLP-1 drugs used for weight loss, finding they are associated with a high cost of care with little benefit beyond ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

Coverage for these medications varies widely across plans; while many employers cover GLP-1 for diabetes treatment, fewer ...

GLP-1 medications represent a newer approach to ... your chosen bariatric center, or third parties Compare costs across different locations while prioritizing reputable clinics Calculate potential ...

"The popularity of GLP-1 drugs as a treatment for obesity meets a sobering reality of poor adherence and high cost of care in the real world, and it may be quite some time before these measures ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...

Spending on GLP-1s in Medicaid has followed broader industry trends, growing significantly over the past several years, according to a ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday.